| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.25 | 1e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.1 |